CerS6 Is a Novel Transcriptional Target of p53 Protein Activated by Non-genotoxic Stress

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · see citing works

Ferroptosis as a p53-mediated activity during tumour suppression

Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · see citing works

Principles of bioactive lipid signalling: lessons from sphingolipids

Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,331 · see citing works

Blinded by the Light: The Growing Complexity of p53

Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · see citing works

TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis

Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · see citing works

Definition of a consensus binding site for p53

El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · see citing works

Transcriptional control of human p53-regulated genes

Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · see citing works

p53 Regulates Mitochondrial Respiration

Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · see citing works

PROMO: detection of known transcription regulatory elements using species-tailored searches

Messeguer, X., Escudero, R., Farré, D., Núñez, Ó., Martı́nez, J., & Albà, M. M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.2.333 · Cited by 1,371 · see citing works

Sphingolipid metabolites in inflammatory disease

Maceyka, M. W., & Spiegel, S. (2014) · Nature · doi:10.1038/nature13475 · Cited by 1,284 · see citing works

A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome

Wei, C.-L., Wu, Q., Vega, V. B., Chiu, K. P., Ng, P., Zhang, T., Shahab, A., Yong, H. C., Fu, Y., Weng, Z., et al. (2006) · Cell · doi:10.1016/j.cell.2005.10.043 · Cited by 1,141 · see citing works

P53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works

Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN

Farré, D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg605 · Cited by 1,041 · see citing works

Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function

Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862 · see citing works

The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression

Bar‐Yoseph, F., Armoni, M., & Karnieli, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0846 · Cited by 728 · see citing works

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species

Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705 · see citing works

The complex life of simple sphingolipids

Futerman, A. H., & Hannun, Y. A. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400208 · Cited by 666 · see citing works

p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation

Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 635 · see citing works

Transcriptional Regulation by P53

Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569 · see citing works

The expanding universe of p53 targets

Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568 · see citing works

Ceramide synthases at the centre of sphingolipid metabolism and biology

Mullen, T. D., Hannun, Y. A., & Obeid, L. M. (2012) · Biochemical Journal · doi:10.1042/bj20111626 · Cited by 541 · see citing works

Transcriptional regulation by p53: one protein, many possibilities

Laptenko, O., & Prives, C. L. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401916 · Cited by 500 · see citing works

p53 Enters the MicroRNA World

Hermeking, H. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.028 · Cited by 494 · see citing works

Metabolic Regulation by p53 Family Members

Berkers, C. R., Maddocks, O. D. K., Cheung, E. C., Mor, I., & Vousden, K. H. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.06.019 · Cited by 443 · see citing works

Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect

Zhang, C., Lin, M., Wu, R., Wang, X., Yang, B., Levine, A. J., Hu, W., & Feng, Z. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113884108 · Cited by 431 · see citing works

Ceramide: A simple sphingolipid with unique biophysical properties

Castro, B. M., PRIETO, M. J. E., & Silva, L. C. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.01.004 · Cited by 385 · see citing works

Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome?

Cremesti, A. E., Goñi, F. M., & Kolesnick, R. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03489-0 · Cited by 342 · see citing works

Glucose Catabolism in Cancer Cells

Mathupala, S. P., Heese, C., & Pedersen, P. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.36.22776 · Cited by 231 · see citing works

Ceramide synthases as potential targets for therapeutic intervention in human diseases

Park, J., Park, W., & Futerman, A. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.08.019 · Cited by 231 · see citing works

Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents.

Tishler, R. B., Calderwood, S. K., Coleman, C. N., & Price, B. D. (1993) · PubMed · Cited by 200 · see citing works

Diverse Functions of Ceramide in Cancer Cell Death and Proliferation

Saddoughi, S. A., & Öğretmen, B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-394274-6.00002-9 · Cited by 176 · see citing works

Ceramide Synthases: Roles in Cell Physiology and Signaling

Stiban, J., Tidhar, R., & Futerman, A. H. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_4 · Cited by 172 · see citing works

p53 Protein-mediated Regulation of Phosphoglycerate Dehydrogenase (PHGDH) Is Crucial for the Apoptotic Response upon Serine Starvation

Ou, Y., Wang, S.-J., Jiang, L., Zheng, B., & Gu, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.616359 · Cited by 154 · see citing works

The transcription factor p53: Not a repressor, solely an activator.

Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153 · see citing works

Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy

Choong, M. L., Yang, H. C., Lee, M. A., & Lane, D. P. (2009) · Cell Cycle · doi:10.4161/cc.8.17.9503 · Cited by 141 · see citing works

Regulation of lipid metabolism by p53 – fighting two villains with one sword

Goldstein, I., & Rotter, V. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2012.06.007 · Cited by 121 · see citing works

Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model

Sanchez‐Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.168 · Cited by 112 · see citing works

Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome

Neilsen, P. M., Noll, J. E., Suetani, R. J., Schulz, R. B., Al‐Ejeh, F., Evdokiou, A., Lane, D. P., & Callen, D. F. (2011) · Oncotarget · doi:10.18632/oncotarget.382 · Cited by 112 · see citing works

Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines

Crott, J. W., Liu, Z., Keyes, M. K., Choi, S.-W., Jang, H., Moyer, M. P., & Mason, J. B. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.05.003 · Cited by 103 · see citing works

A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network

Menéndez, D., Krysiak, O., Inga, A., Krysiak, B., Resnick, M. A., & Schönfelder, G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508103103 · Cited by 82 · see citing works

MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP

Zhang, X., Schulz‐Heddergott, R., Edmunds, S. J., Krüger, E., Markert, E. K., Gaedcke, J., Cormet‐Boyaka, E., Ghadimi, M. B., Beißbarth, T., Levine, A. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.036 · Cited by 78 · see citing works

Folate Stress Induces Apoptosis via p53-dependent de Novo Ceramide Synthesis and Up-regulation of Ceramide Synthase 6

Hoeferlin, L. A., Fekry, B., Öğretmen, B., Krupenko, S. A., & Krupenko, N. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.461798 · Cited by 72 · see citing works

De novo N-palmitoylsphingosine synthesis is the major biochemical mechanism of ceramide accumulation following p53 up-regulation

Panjarian, S., Kozhaya, L., Arayssi, S., Yehia, M., Bielawski, J., Bielawska, A., Usta, J., Hannun, Y. A., Obeid, L. M., & Dbaibo, G. S. (2008) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2008.02.004 · Cited by 69 · see citing works

Concerted functions of HDAC1 and microRNA‐574‐5p repress alternatively spliced ceramide synthase 1 expression in human cancer cells

Meyers‐Needham, M., Ponnusamy, S., Gencer, S., Jiang, W., Thomas, R. J., Senkal, C. E., & Öğretmen, B. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100189 · Cited by 67 · see citing works

Epigenetic Silencing of ALDH1L1, a Metabolic Regulator of Cellular Proliferation, in Cancers

Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2011) · Genes & Cancer · doi:10.1177/1947601911405841 · Cited by 60 · see citing works

Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress

Hoeferlin, L. A., Oleinik, N. V., Krupenko, N. I., & Krupenko, S. A. (2011) · Genes & Cancer · doi:10.1177/1947601911432495 · Cited by 60 · see citing works

To be, or not to be

Wang, S.-J., & Gu, W. J. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000024 · Cited by 57 · see citing works

To repress or not to repress: This is the guardian's question

Rinn, J. L., & Huarte, M. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.002 · Cited by 56 · see citing works

p53-dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene

Wang, S.-J., Yu, G., Jiang, L., Li, T., Lin, Q., Tang, Y., & Gu, W. (2013) · Cell Cycle · doi:10.4161/cc.23597 · Cited by 54 · see citing works

Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner

Fekry, B., Esmaeilniakooshkghazi, A., Krupenko, S. A., & Krupenko, N. I. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146618 · Cited by 52 · see citing works

Cancer cells activate p53 in response to 10-formyltetrahydrofolate dehydrogenase expression

Oleinik, N. V., Krupenko, N. I., Priest, D. G., & Krupenko, S. A. (2005) · Biochemical Journal · doi:10.1042/bj20050533 · Cited by 47 · see citing works

Membrane Channels Formed by Ceramide

Colombini, M. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1368-4_6 · Cited by 46 · see citing works

Ceramide synthases CerS4 and CerS5 are upregulated by 17β-estradiol and GPER1 via AP-1 in human breast cancer cells

Wegner, M.-S., Wanger, R. A., Oertel, S., Brachtendorf, S., Hartmann, D., Schiffmann, S., Marschalek, R., Schreiber, Y., Ferreirós, N., Geißlinger, G., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.10.007 · Cited by 46 · see citing works

Dissecting microregulation of a master regulatory network

Sinha, A. U., Kaimal, V., Chen, J., & Jegga, A. G. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-88 · Cited by 44 · see citing works

p53 and regulation of bioactive sphingolipids

Heffernan-Stroud, L. A., & Obeid, L. M. (2010) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2010.10.003 · Cited by 33 · see citing works

Potentiating the p53 network.

Menéndez, D., Inga, A., & Resnick, M. A. (2010) · PubMed · Cited by 32 · see citing works

Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5–8 of the gene

Crott, J. W., Liu, Z., Choi, S., & Mason, J. B. (2006) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2006.10.001 · Cited by 26 · see citing works

Baculovirus Expression and Purification of Rat 10-Formyltetrahydrofolate Dehydrogenase

Krupenko, S. A., Horstman, D. A., Wagner, C., & Cook, R. (1995) · Protein Expression and Purification · doi:10.1006/prep.1995.1061 · Cited by 20 · see citing works

Sphingolipid metabolism in cancer signalling and therapy

Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207 · see citing works

Census and evaluation of p53 target genes

Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971 · see citing works

Metabolic functions of the tumor suppressor p53: Implications in normal physiology, metabolic disorders, and cancer

Lacroix, M., Riscal, R., Arena, G., Linares, L. K., & Cam, L. L. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.002 · Cited by 367 · see citing works

Bioactive lipids, inflammation and chronic diseases

Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 368 · see citing works

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis

Quinville, B. M., Deschenes, N. M., Ryckman, A. E., & Walia, J. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115793 · Cited by 348 · see citing works

The complexity of p53-mediated metabolic regulation in tumor suppression

Liu, Y., & Gu, W. J. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.03.010 · Cited by 260 · see citing works

Exploring the multiple roles of guardian of the genome: P53

Feroz, W., & Sheikh, A. M. A. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00089-x · Cited by 161 · see citing works

C16-ceramide is a natural regulatory ligand of p53 in cellular stress response

Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Szulc, Z. M., Knagge, K. J., Kirchner, D. R., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2018) · Nature Communications · doi:10.1038/s41467-018-06650-y · Cited by 102 · see citing works

Mechanisms of Ceramide-Dependent Cancer Cell Death

Nganga, R., Oleinik, N. V., & Öğretmen, B. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.007 · Cited by 87 · see citing works

Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma

Krautbauer, S., Haberl, E. M., Rein‐Fischboeck, L., Pohl, R., Weiß, T. S., Sigrüener, A., Aslanidis, C., Liebisch, G., & Buechler, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.08.014 · Cited by 85 · see citing works

The Role of Ceramide Metabolism and Signaling in the Regulation of Mitophagy and Cancer Therapy

Sheridan, M., & Öğretmen, B. (2021) · Cancers · doi:10.3390/cancers13102475 · Cited by 79 · see citing works

Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2

Xu, R., Garcı́a-Barros, M., Wen, S., Li, F., Lin, C., Hannun, Y. A., Obeid, L. M., & Mao, C. (2017) · Cell Death and Differentiation · doi:10.1038/s41418-017-0018-y · Cited by 72 · see citing works

Ceramide Signaling and p53 Pathways

Jeffries, K. A., & Krupenko, N. I. (2018) · Advances in cancer research · doi:10.1016/bs.acr.2018.04.011 · Cited by 64 · see citing works

Loss of ALDH1L1 folate enzyme confers a selective metabolic advantage for tumor progression

Krupenko, S. A., & Krupenko, N. I. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.02.013 · Cited by 51 · see citing works

p53 regulates lipid metabolism in cancer

Chen, L., & Wang, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.09.188 · Cited by 50 · see citing works

Rotten to the Cortex: Ceramide-Mediated Lipotoxicity in Diabetic Kidney Disease

Nicholson, R. J., Pezzolesi, M. G., & Summers, S. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.622692 · Cited by 49 · see citing works

Emerging roles and therapeutic potentials of sphingolipids in pathophysiology: emphasis on fatty acyl heterogeneity

Mu, J., Lam, S. M., & Shui, G. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.06.006 · Cited by 47 · see citing works

Association between abnormal lipid metabolism and tumor

Li, C., Wang, F., Cui, L., Li, S., Zhao, J., & Liao, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1134154 · Cited by 42 · see citing works

Metabolic regulation by p53: Implications for cancer therapy

Koo, K. Y., Moon, K., He, S., & Lee, M.-S. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100198 · Cited by 40 · see citing works

The role of tumor suppressor p53 in metabolism and energy regulation, and its implication in cancer and lifestyle-related diseases

Hashimoto, N., Nagano, H., & Tanaka, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0565 · Cited by 35 · see citing works

Ceramide–Rubusoside Nanomicelles, a Potential Therapeutic Approach to Target Cancers Carrying p53 Missense Mutations

Khiste, S., Liu, Z., Roy, K. R., Uddin, M. B., Hosain, S. B., Gu, X., Nazzal, S., Hill, R. A., & Liu, Y. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-19-0366 · Cited by 34 · see citing works

The heat shock protein Hsp27 controls mitochondrial function by modulating ceramide generation

Boyd, R. A., Majumder, S., Stiban, J., Mavodza, G. R., Straus, A. J., Kempelingaiah, S. K., Reddy, V., Hannun, Y. A., Obeid, L. M., & Senkal, C. E. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113081 · Cited by 31 · see citing works

Expression of matrix metalloproteinase 12 is highly specific for non-proliferating invasive trophoblasts in the first trimester and temporally regulated by oxygen-dependent mechanisms including HIF-1A

Hiden, U., Eyth, C. P., Majali‐Martinez, A., Desoyé, G., Tam‐Amersdorfer, C., Huppertz, B., & Ghaffari‐Tabrizi‐Wizsy, N. (2017) · Histochemistry and Cell Biology · doi:10.1007/s00418-017-1608-y · Cited by 31 · see citing works

Receptor-interacting Ser/Thr kinase 1 (RIPK1) and myosin IIA–dependent ceramidosomes form membrane pores that mediate blebbing and necroptosis

Nganga, R., Oleinik, N. V., Kim, J., Selvam, S. P., Palma, R. M. D., Johnson, K. A., Parikh, R. Y., Gangaraju, V. K., Peterson, Y. K., Dany, M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005865 · Cited by 30 · see citing works

Transcriptome analysis of polyploid giant cancer cells and their progeny reveals a functional role for p21 in polyploidization and depolyploidization

White‐Gilbertson, S. J., Lü, P., Saatci, Ö., Şahin, Ö., Delaney, J. R., Öğretmen, B., & Voelkel‐Johnson, C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107136 · Cited by 23 · see citing works

Sphingolipids in embryonic development, cell cycle regulation, and stemness – Implications for polyploidy in tumors

Voelkel‐Johnson, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.027 · Cited by 22 · see citing works

Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers

Trapika, I. G. M. G. S. C., Liu, X. T., Chung, L. H., Lai, F., Xie, C., Zhao, Y., Cui, S., Chen, J., Tran, C., Wang, Q., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738078 · Cited by 20 · see citing works

Sphingolipids and the link between alcohol and cancer

Barron, K. A., Jeffries, K. A., & Krupenko, N. I. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109058 · Cited by 19 · see citing works

Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study

Liang, L., Li, D., Zeng, R., Zhang, H., Lv, L., Wei, W., & Wan, Z. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01831-6 · Cited by 18 · see citing works

Exercise Promotes Pro-Apoptotic Ceramide Signaling in a Mouse Melanoma Model

Lee, J., Savage, H., Maegawa, S., Ballarò, R., Pareek, S., Guerrouahen, B. S., Gopalakrishnan, V., & Schadler, K. (2022) · Cancers · doi:10.3390/cancers14174306 · Cited by 16 · see citing works

CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation

Shi, H., Niimi, A., Takeuchi, T., Shiogama, K., Mizutani, Y., Kajino, T., Inada, K., Hase, T., Hatta, T., Shibata, H., et al. (2021) · Cancer Science · doi:10.1111/cas.14928 · Cited by 14 · see citing works

Mass Spectrometry Detects Sphingolipid Metabolites for Discovery of New Strategy for Cancer Therapy from the Aspect of Programmed Cell Death

Shi, M., Tang, C., Wu, J.-X., Ji, B.-W., Gong, B., Wu, X., & Wang, X. (2023) · Metabolites · doi:10.3390/metabo13070867 · Cited by 13 · see citing works

Maintaining intestinal structural integrity is a potential protective mechanism against inflammation in goose fatty liver

Gu, W., Wen, K., Yan, C., Li, S., Liu, T., Cheng, X., Liu, L., Zhao, M., Zhang, J., Geng, T., et al. (2020) · Poultry Science · doi:10.1016/j.psj.2020.08.052 · Cited by 13 · see citing works

The Role of Lipids in Hepatocellular Carcinoma

Hayes, C. N., Zhang, P., & Chayama, K. (2019) · Codon Publications eBooks · doi:10.15586/hepatocellularcarcinoma.2019.ch5 · Cited by 12 · see citing works

Ceramide Synthase 6: Comparative Analysis, Phylogeny and Evolution

Holmes, R. S., Barron, K. A., & Krupenko, N. I. (2018) · Biomolecules · doi:10.3390/biom8040111 · Cited by 11 · see citing works

Sphingolipid Metabolism in Tumor Cells

Pokrovsky, V. S., Иванова-Радкевич, В. И., & Kuznetsova, O. M. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923070015 · Cited by 8 · see citing works

The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury

Liu, Y., Sun, Z., Sun, Q., Wang, L., Wang, C., Li, Y., Ma, C., Shi, W., Zhang, G., Dong, Y., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02019-x · Cited by 6 · see citing works

Heat shock protein (Hsp27)-ceramide synthase (Cers1) protein-protein interactions provide a new avenue for unexplored anti-cancer mechanism and therapy

Ali, M., Zhang, Z., Ibrahim, M. A. A., & Soliman, M. E. S. (2024) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2024.2392711 · Cited by 5 · see citing works

Dietary Folic Acid Alters Metabolism of Multiple Vitamins in a CerS6- and Sex-Dependent Manner

Barron, K. A., Öğretmen, B., & Krupenko, N. I. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.758403 · Cited by 5 · see citing works

Expression of the SNAI2 transcriptional repressor is regulated by C16-ceramide

Lü, P., White‐Gilbertson, S. J., Nganga, R., KESTER, M. A., & Voelkel‐Johnson, C. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1579962 · Cited by 5 · see citing works

Drug Targeting of Acyltransferases in the Triacylglyceride and 1-O-AcylCeramide Biosynthetic Pathways

Hernandez‐Corbacho, M. J., & Canals, D. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000763 · Cited by 4 · see citing works

Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancer

Xing, J., & Yi, J. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00868-z · Cited by 4 · see citing works

Identifying the location of epidermal growth factor‐responsive element involved in the regulation of type II b sodium‐phosphate cotransporter expression in porcine intestinal epithelial cells

Xing, T., Tan, X., Yu, Q., Yang, T., & Fang, R. (2016) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12645 · Cited by 3 · see citing works

Advances in ORMDL Research in Malignant Tumors: A Review

Wang, H., Yi, Z., Yan, S., Wang, Y., Zhang, W., Guo, R., Li, Y., Wang, R., Li, H., Li, X., et al. (2025) · OncoTargets and Therapy · doi:10.2147/ott.s537194 · Cited by 2 · see citing works

An integrative approach to studying sphingolipid metabolism reveals p53 as a master regulator of the pathway

Ghandour, B., Amin, S., Medatwal, N., Lee, A. H., Yu, G.-Q., Resnick, A. E., Chiappone, S. B., Clarke, C. J., Canals, D., Hannun, Y. A., et al. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.100994 · Cited by 2 · see citing works

Sphingolipids in Cancer: Metabolism, Signaling, and Clinical Implications

Desai, S. A., Nagare, S. D., Patel, V. P., Pagare, N. B., & Jangam, T. C. (2025) · Drug Metabolism and Bioanalysis Letters · doi:10.2174/0118723128377799250214075521 · Cited by 1 · see citing works

Ceramides and associated key enzymes at the evolutionary crossroad of colorectal inflammatory immune responses and tumorigenesis

Su, H., Li, Y., Li, Z., Li, S., Pan, J., Ji, G., Lu, L., & Xu, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.146916 · Cited by 1 · see citing works

The p53–CerS6 interaction on the ER integrates p53 and sphingolipid signaling pathways in metabolic stress response

Childress, M. S., Jeffries, K. A., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101097 · Cited by 1 · see citing works

Faculty Opinions recommendation of Sphingolipid metabolism in cancer signalling and therapy.

Loughran, T. P., & Tan, S. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732125735.793546487

Sphingolipid Metabolism in Cancer: Potential Therapeutic Target

Moumneh, M. B., Dargham, T. B., Mrad, M., & Dbaibo, G. S. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_264-1

Metabolism of sphingolipids in tumor cells

Pokrovsky, V. S., Иванова-Радкевич, В. И., & Kuznetsova, O. (2023) · Biochemistry (Moscow) · doi:10.31857/s0320972523070011

Sphingolipid Metabolism in Cancer: Potential Therapeutic Target

Moumneh, M. B., Dargham, T. B., Mrad, M., & Dbaibo, G. S. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_264

Additional file 2 of Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study

Liang, L., Li, D., Zeng, R., Zhang, H., Lv, L., Wei, W., & Wan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26583909

Additional file 1 of The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury

Liu, Y., Sun, Z., Sun, Q., Wang, L., Wang, C., Li, Y., Ma, C., Shi, W., Zhang, G., Dong, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25330813

Additional file 1 of Long- and very long-chain ceramides are predictors of acute kidney injury in patients with acute coronary syndrome: the PEACP study

Liang, L., Li, D., Zeng, R., Zhang, H., Lv, L., Wei, W., & Wan, Z. (2023) · Figshare · doi:10.6084/m9.figshare.26583906

Osteoarthritis Bone Marrow MSCs Retain Regenerative Competence and Chemokine Responsiveness for Drug‐Based In Situ Tissue Engineering

Sonnleitner, J., Gulich, K., Prüß, A., Perka, C., Gursche, A., Kendoff, D., Sittinger, M., Hemmati‐Sadeghi, S., & Dehne, T. (2025) · Stem Cells International · doi:10.1155/sci/3757831

Le métabolisme des céramides hypothalamiques induit une résistance à l’insuline centrale et une dérégulation de l’homéostasie glucidique durant l’installation de l’obésité

Campaña, M. B. (2017) · theses.fr (ABES) · doi:10.70675/22c9fea8z8ac8z4640z9f7bza2bb8118ab2e

Determinants of C16-Ceramide Binding to p53

Childress, M. S., Jeffries, K. A., Krupenko, S. A., & Krupenko, N. I. (2026) · Biomolecules · doi:10.3390/biom16091343

Ceramide synthesis mediates colorectal cancer metastasis through a YAP-driven regenerative program

Goswami, S., Zhang, Q., Yıldız, A. B., Adhikari, U. D., Raghawan, A. K., Bulliard, M., Sedhain, S., Darawshi, O., Celik, C. E., Cansiz, F., et al. (2026) · Science · doi:10.1126/science.adw8520

The p53–CerS6 interaction on the ER integrates p53 and sphingolipid signaling pathways in metabolic stress response

Childress, M. S., Jeffries, K. A., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101097 · Cited by 1 · see citing works

C 16 ‐Ceramide directly binds and activates p53 in response to cellular stress

Jeffries, K. A., & Krupenko, N. I. (2019) · The FASEB Journal · doi:10.1096/fasebj.2019.33.1_supplement.lb274

Determinants of C16-Ceramide Binding to p53

Childress, M. S., Jeffries, K. A., Krupenko, S. A., & Krupenko, N. I. (2026) · Biomolecules · doi:10.3390/biom16091343

C16-ceramide is a natural regulatory ligand of p53 in cellular stress response

Fekry, B., Jeffries, K. A., Esmaeilniakooshkghazi, A., Szulc, Z. M., Knagge, K. J., Kirchner, D. R., Horita, D. A., Krupenko, S. A., & Krupenko, N. I. (2018) · Nature Communications · doi:10.1038/s41467-018-06650-y · Cited by 102 · see citing works

p53-dependent ceramide response to genotoxic stress.

Dbaibo, G. S., Pushkareva, M. Y., Rachid, R. A., Alter, N., Smyth, M. J., Obeid, L. M., & Hannun, Y. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1180 · Cited by 162 · see citing works